CVS Health (CVS) Stock Forecast & Price Target
Score
CVS Health Corp. price target
| CVS | |
|---|---|
| Low | $103.00 |
| Average | $110.59 |
| High | $123.00 |
| Upside vs current price | +23.8% |
The average target of $110.59 is +23.8% versus the current CVS price of $89.35.
CVS Health Corp. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 7 |
| Buy | 18 |
| Hold | 3 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
28 analysts cover CVS.
CVS Health Corp. EPS and revenue estimates
Published annual figures for CVS on this page are 2026 EPS $8.25, 2027 EPS $8.68. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $8.25 | $420.89B |
| 2027 | $8.68 | $431.45B |
Is CVS Health Corp. a buy or sell?
Of the 28 analysts covering CVS Health Corp., 25 rate it a buy (7 strong buy and 18 buy), 3 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The CVS consensus label is Buy, beside 25 buy-side ratings and 0 sell-side ratings.
The average target of $110.59 implies +23.8% versus the current price of $89.35.
The CVS rating block is 28 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the CVS Health Corp. forecast
the CVS Health Corp. is priced by the street between $103.00 and $123.00, average $110.59.
The gap from the $89.35 price to the CVS average is +23.8%.
The CVS rating mix is lopsided rather than split: 25 of 28 analysts are on the buy side, 3 are at hold, and 0 are on the sell side, and the published consensus is Buy.
The recent CVS average ($108.40) is under the quarterly figure ($111.09).
the CVS Health Corp. is followed by 28 analysts, so the range matters more than any one target.
CVS Health Corp. forecast questions
What is the CVS price target?
The published range for CVS is $103.00 to $123.00, with an average of $110.59. That average is +23.8% versus the current price of $89.35.
Is CVS Health Corp. a buy or sell?
Of the 28 analysts covering CVS Health Corp., 25 rate it a buy, 3 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving CVS at 25 buy ratings, 3 holds, and 0 sells.
What is the EPS estimate for CVS Health Corp.?
Analyst EPS estimates for CVS Health Corp.: 2026 $8.25, 2027 $8.68.
What is the revenue estimate for CVS Health Corp.?
Analyst revenue estimates for CVS Health Corp.: 2026 $420.89B, 2027 $431.45B.
How many analysts cover CVS?
28 analysts cover CVS. Their consensus on CVS is Buy, across those 28.